DR-CAFTA's Impact on Drugs' Affordability: the Case of AIDS
The main objective of this Regional Technical Cooperation (RTC) is to analyze the DR-CAFTA with regard to its chapter on intellectual property rights (IPR) in order to identify DR-CAFTA's consequences on access to essential medicine and its differential effects for each participating LAC country (Costa Rica, Dominican Republic, El Salvador, Guatemala, Honduras and Nicaragua). More particularly, the RTC will study AIDS' drugs affordability as an illustration of the impact of the Agreement both considering each country's relative needs and current position with regards to IPR.

Project Detail

Country

Regional

Project Number

RG-T1245

Approval Date

November 1, 2006

Project Status

Closed

Project Type

Technical Cooperation

Sector

HEALTH

Subsector

HEALTH SERVICES

Lending Instrument

-

Lending Instrument Code

-

Modality

-

Facility Type

-

Environmental Classification

-

Total Cost

USD 150,000.00

Country Counterpart Financing

USD 0.00

Original Amount Approved

USD 150,000.00
Financial Information
Operation Number Lending Type Reporting Currency Reporting Date Signed Date Fund Financial Instrument
ATN/SF-10083-RG Sovereign Guaranteed USD - United States Dollar Fund for Special Operations Nonreimbursable
Operation Number ATN/SF-10083-RG
  • Lending Type: Sovereign Guaranteed
  • Reporting Currency: USD - United States Dollar
  • Reporting Date:
  • Signed Date:
  • Fund: Fund for Special Operations
  • Financial Instrument: Nonreimbursable